Olema Pharmaceuticals Inc (OLMA) Company Profile & Statistics

Olema Pharmaceuticals Inc
OLMA
(Nasdaq - US)
N/A
10.37
+0.20 (+1.97%)
in:usd•As of: May 01, 2024 15:59 UTC -4
Open
10.20
High
10.77
Low
10.20

About Olema Pharmaceuticals Inc

CEO

Sean Bohen

Headquarters

780 brannan street

san francisco, ca 94103, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.olema.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Olema Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in discovery, development and commercialization of therapies for women's cancers. The company's product pipeline includes OP-1250, which is in clinical stage. Olema Pharmaceuticals Inc. is based in San Francisco, California.

Olema Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	579.99M
Enterprise Value	511.46M
Enterprise Value/EBITDA (ttm)	-4.89
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.20
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-44.67%
Return on Invested Capital (ttm)	-46.96%
Return on Assets (ttm)	-40.99%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-104.58M
Net Income Avi to Common (ttm)	-96.66M
Diluted EPS (ttm)	-2.16

Share Statistics

Beta (5Y Monthly)	2.10
52-Week Change	90.98%
S&P500 52-Week Change	23.73%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	55.91M
Dividend Yield	0.00%
Float ⁴	42.77M
% Held by Insiders	23.50%
% Held by Institutions	91.78%

Balance Sheet

Total Cash (mrq)	261.81M
Total Cash Per Share (mrq)	4.68
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	12.33%
Quick Ratio (mrq)	12.33%
Book Value Per Share (mrq)	4.62

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.85
Free Cash Flow (ytd)	-83.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Olema Pharmaceuticals Inc

Trade With A Regulated Broker